Maxi Nicotine Lozenge
Product Images NDC 0536-1338

1 FDA label image from Rugby Laboratories, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Maxi Nicotine (NDC 0536-1338). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rugby Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nicotine Polacrilex Usp, 4 mg (Nicotine 4 mg Mint Maxi Lozenge Rub 1)

Nicotine Polacrilex Usp, 4 mg (Nicotine 4 mg Mint Maxi Lozenge Rub 1)
The labeling for Maxi Nicotine Polacrilex Lozenges 4 mg, a mint-flavored stop smoking aid by Rugby Laboratories, Inc. The package contains 72 lozenges divided into 3 containers of 24 each. The front panel highlights the product name and strength, associated warnings, directions, inactive ingredients, and a barcode. It states the product is for oral use and targets smokers who have their first cigarette within 30 minutes of waking up.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.